Medpace Holdings, Inc.
MEDP
$298.55
-$4.33-1.43%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Revenue | 9.87% | 11.84% | 16.24% | 21.36% | 25.57% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 9.87% | 11.84% | 16.24% | 21.36% | 25.57% |
| Cost of Revenue | 4.52% | 6.87% | 10.45% | 14.44% | 17.51% |
| Gross Profit | 12.58% | 14.38% | 19.29% | 25.10% | 30.08% |
| SG&A Expenses | 15.89% | 11.67% | 16.44% | 15.87% | 19.52% |
| Depreciation & Amortization | 6.68% | 11.10% | 13.71% | 16.18% | 17.99% |
| Other Operating Expenses | 4.50% | 6.58% | 17.14% | 30.64% | 40.11% |
| Total Operating Expenses | 5.73% | 7.31% | 14.18% | 21.76% | 27.38% |
| Operating Income | 28.65% | 32.67% | 25.43% | 19.63% | 17.96% |
| Income Before Tax | 32.80% | 41.78% | 35.82% | 25.17% | 19.39% |
| Income Tax Expenses | 30.03% | 35.30% | 47.63% | 17.94% | 7.11% |
| Earnings from Continuing Operations | 33.24% | 42.99% | 33.85% | 26.48% | 21.62% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 33.24% | 42.99% | 33.85% | 26.48% | 21.62% |
| EBIT | 28.65% | 32.67% | 25.43% | 19.63% | 17.96% |
| EBITDA | 27.08% | 31.11% | 24.58% | 19.39% | 17.96% |
| EPS Basic | 32.81% | 42.04% | 33.66% | 27.08% | 24.12% |
| Normalized Basic EPS | 32.18% | 40.73% | 35.50% | 25.68% | 21.91% |
| EPS Diluted | 33.55% | 42.24% | 33.86% | 27.13% | 24.31% |
| Normalized Diluted EPS | 32.83% | 41.02% | 35.67% | 25.82% | 22.16% |
| Average Basic Shares Outstanding | 0.52% | 0.76% | 0.19% | -0.46% | -2.37% |
| Average Diluted Shares Outstanding | 0.06% | 0.57% | 0.07% | -0.57% | -2.58% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |